Nutrapharm launches Setria-powered supplement, marking a regulatory milestone for the clinically researched ingredient in South America NEW YORK, June 11, 2026 /PRNewswire/ -- Kyowa Hakko, a global leader in health ingredient innovation and manufacturer of branded ingredient Setria Glutathione, today announced that a supplement featuring Setria has been approved for sale in Chile through the Secretara Regional Ministerial (SEREMI) de Salud
It should not imply that a catalog item has the same setting, purpose, or evidentiary status as any study material
Functional roles and novel tools for improving-oxidative stability of polyunsaturated fatty acids: a comprehensive review
58.9% men) and 34,196 started a DPP4 inhibitor (median age, 63 years
After receiving FDA approval for use, these GLP-1 (glucagon-like peptide 1)- based drugs have been described as game changers in the fight against obesity